The equities markets were quite erratic today, with the major indexes mostly trading in a narrow range. The healthcare sector ETF XLV was up about +1% for the session, and the biotech ETF IBB was up +1.39%, once again showing stronger recovery in biotech versus the overall healthcare sector. However, both ETFs traded in narrow ranges after gapping higher. Meanwhile, strong price movement was seen in EDGE, BIOS, and NVAX. Here’s a recap of today’s action.
Rates are driving everything right now and Friday’s jobs report could swing October hike odds significantly. Scott Bauer joined the IBKR Podcast to break down what he is watching most closely, which sectors he likes heading into earnings, and the one underlying risk he thinks is not getting enough attention.
Read Article
THE JEFFERSONS Why am I featuring George & Louise this week? Well, just like them, rates are MOVIN’ ON UP! We will get into more detail below. Despite all that volatility over the past few days, the stock market put together a pretty decent week. It certainly was a rollercoaster of a week on Wall Street, […]
Read Article
RISING PRICES The Dow, S&P 500, Nasdaq 100, and Russell 2000 all struggled this week, despite a Thursday rebound and an extremely muted triple witching expiration on Friday. Investors digested a Federal Reserve rate hike, a higher 10-year Treasury yield, renewed Iran-related energy risk, and fresh uncertainty around the AI investment cycle. Geopolitics remains a major […]
Read Article
Scott Bauer joined the IBKR Podcast this week to break down what moved markets last week and what investors need to watch heading into the next stretch of earnings season. From lagging inflation data to big tech CapEx concerns, Scott did not hold back.
Read Article
The Dow rose more than 1% to a record closing high on Thursday ahead of the long holiday weekend as a softer-than-expected U.S. jobs report eased worries about interest rate hikes, while another sharp drop in chipmaker stocks weighed on the Nasdaq. The second half of 2026 kicked off this week much the same as […]
Read Article
A renewed sell-off in technology stocks grabbed headlines this week. The Nasdaq index fell 4.5%, closing lower 5 days in a row, led by a large 5.5% decline in the so-called Magnificent 7 mega cap names. Meanwhile, the post IPO exuberance around SpaceX appears to be fading, with shares now down 25% from their peak. […]
Read ArticleWe choose to let our members and students speak for themselves. We do not actively solicit testimonials, no compensation has been paid for any testimonial, and testimonials are not necessarily representative of the experience of all students. All monetary claims made in testimonials that you see depicted in our marketing material have been verified by Prosper Trading Academy and attested to by the members that have given them. Verified testimonials encompass “experience” reviews that highlight the personal experiences of working with our team and “performance” testimonials where we verify trading success of students who have enrolled in our programs.Given the broad reach of the internet, testimonials and reviews of our programs that we have not been able to verify can be found on various websites across the internet which are beyond our editorial control. While we do very much enjoy hearing positive things from our students and it is critical to our mission that everyone is satisfied with their journey with Prosper, we encourage you to take both verified and unverified testimonials for what they are.